256 records found.
Jan 14, 2020
John Theurer Cancer Center Investigators Report Poor Colorectal Cancer Biomarker Testing Rates
Jan 08, 2020
Blueprint Medicines Announces Top-line Data for Pralsetinib and Initiates Rolling NDA Submission to FDA for the Treatment of Patients with RET Fusion-Positive Non-Small Cell Lung Cancer
Jan 07, 2020
genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models
Jan 07, 2020
GNS Healthcare Announces Strategic Investment from Merck Global Health Innovation Fund
Jan 06, 2020
InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab
Jan 06, 2020
Clinical Update - 4D Announce New Study of MRx0518 in Pancreatic Cancer
Dec 20, 2019
InxMed Receives Approval to Initiate Phase I Clinical Trial in China for IN10018
Dec 19, 2019
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega
Dec 18, 2019
BioInvent Has Entered Into a Clinical Trial Collaboration and Supply Agreement to Evaluate BI-1206 in Combination With KEYTRUDA® in Advanced Solid Tumors
Dec 18, 2019
Merck Foundation CEO, Rasha Kelej Named Among Top 100 Most Influential Africans
Dec 16, 2019
Futility Analysis Performed of the Phase II Combination Study with Birinapant and Keytruda® in Colorectal Cancer Patients
Dec 11, 2019
StayWell Shares Top 5 Employer Wellness Trends in 2020
Dec 10, 2019
EMD Serono and the pan-Canadian Pharmaceutical Alliance Complete Negotiations for MAVENCLAD® (cladribine tablets) for the treatment of Relapsing-Remitting Multiple Sclerosis
Dec 04, 2019
PillTracker Ltd. Joins PMatX Innovation Lab, to Accelerate Development With Support From Merck, Flex and Israel Innovation Authority
Dec 04, 2019
Ping An Good Doctor and Merck KGaA, Darmstadt, Germany Form Strategic Collaboration to Advance Intelligent Healthcare in China
Nov 26, 2019
Japan and Singapore Grant CRISPR Patents to MilliporeSigma
Nov 25, 2019
New Survey of Young Adults Uncovers Low Levels of Accurate Knowledge About HIV Transmission Coupled with High-Risk Sexual Behaviors
Nov 20, 2019
Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations
Nov 18, 2019
Cancer Drugs Poised to Improve as New Developments Help Previous Therapies Target Better
Nov 12, 2019
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec

Pages